Skip to main content
SpringerLink
Log in

Absorption enhancement study of astragaloside IV based on its transport mechanism in Caco-2 cells

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The purpose of this study was to investigate the transport characteristics and mechanisms for discovering the possible causes of the low bioavailability of astragaloside IV and to develop an absorption enhancement strategy. Caco-2 cells used as the in vitro model. Results showed a low permeability coefficient (3.7×l0−8cm/s for transport from the AP to BL direction), which remained unchanged throughout the concentration range studied, indicating that the transport of astragaloside IV was predominantly via a passive route. The AP to BL transport of astragaloside IV was found to be highly sensitive to the extracellular Ca2+ concentration, which suggested that its transport may be via a paracellular route. Both chitosan and sodium deoxycholate can increase the permeation efficiency of astragaloside IV. This study indicated that astragaloside IV having a low fraction dose absorbed in humans mainly due to its poor intestinal permeability, high molecular weight, low lipophilicity as well as its paracelluar transport may directly result in the low permeability through its passive transport. Meanwhile, chitosan and sodium deoxycholate can be used as absorption enhancers based on its transport mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hikino, H., Funayama, S., Endo, K. (1976): Hypotensive principle ofAstragalus andHedysarum roots. Planta Med. 30, 297.

    Article  CAS  PubMed  Google Scholar 

  2. Zhang, W.J., Hufnagl, P., Binder, B.R., et al (2003): Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost 90, 904–914.

    CAS  PubMed  Google Scholar 

  3. Bedir, E., Pugh, N., Calis, I., et al (2000): Immunostimulatory effects of cycloartane-type triterpene glycosides fromAstragalus species. Biol. Pharm. Bull 23, 834.

    CAS  PubMed  Google Scholar 

  4. Li, Z.P., Cao, Q. (2002): Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. Acta Pharmacol. Sin. 23, 898–904.

    CAS  PubMed  Google Scholar 

  5. Yang, Q., Lu, J.T., Zhou, A.W., et al (2001): Antinociceptive effect of astragalosides and its mechanism of action. Acta Pharmacol. Sin. 22, 809–12.

    CAS  PubMed  Google Scholar 

  6. Zhang, Y.D., Shen, J.P., Zhu, S.H., et al (1992): Effects of astragalus (ASI, SK) on experimental liver injury. Yao Xue Xue Bao, 27, 401–406.

    CAS  PubMed  Google Scholar 

  7. Ma, Z., Yang, Z. (1999): Scavenging effects ofAstragalus and Gynostemma pentaphyllum with its products on O2− · and · OH, Zhong Yao Cai 22, 303–306.

    CAS  PubMed  Google Scholar 

  8. Luo, Y., Qin, Z., Hong, Z. (2004): Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia, Neuro. Let. 363, 218–223.

    Article  CAS  Google Scholar 

  9. Gu, Y., Wang, G., Pan, G. Y. (2004): Transport and bioavailability studies of astragaloside IV, an active ingredient inRadix astragali. Basic Clin. Pharmacol. Toxicol. 95, 295–298.

    Article  CAS  PubMed  Google Scholar 

  10. Gan, L.S.L., Thakker, D.R. (1997): Applications of the Caco-2 model in the design and development of orally active drugs elucidation of biochemical and physical barriers posed by the intestinal epithelium. Adv. Drug Deliv. Rev. 23, 77–98.

    Article  CAS  Google Scholar 

  11. Artursson, P., Karlsson, J. (1991): Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175, 880–885.

    Article  CAS  PubMed  Google Scholar 

  12. Artursson, P., Magnusson, C. (1990): Epithelial transport of drugs in cell culture. II. Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of the intestinal epithelial (Caco-2) cells. J. Pharm. Sci 79, 595–600.

    Article  CAS  PubMed  Google Scholar 

  13. De Boer, A., Noach, A., Roosemalen, M., et al (1991): Effect of apical and/or basolateral application of EDTA on the permeability of hydrophilic compounds in a human intestinal epithelial cell line (Caco-2). Pharm. Res. 8, S215.

    Google Scholar 

  14. Artursson, P. (1991): Cell cultures as models for drug absoption across the intestinal mucosa. Crit. Rev. Ther. Drug Carrier Syst. 8, 305–330.

    CAS  PubMed  Google Scholar 

  15. Artursson, P., Lindmark, T., Davis, S.S. et al (1994): Effect of chitosa on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11, 1358–1361.

    Article  CAS  PubMed  Google Scholar 

  16. Ilium, L., Farraj, N.F., Davis, S.S. (1994): Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11, 1186–1189.

    Article  Google Scholar 

  17. Schipper, N.G., Varum, K.M., Artursson, P. (1996): Chitosan as absorption enhancers for poorly absorbable drugs. 1. Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm. Res. 13, 1686–1692.

    Article  CAS  PubMed  Google Scholar 

  18. Shin, S.C., Bum, J.P., Choi, J.S. (2000): Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int. J. Pharm. 209, 37–43.

    Article  CAS  PubMed  Google Scholar 

  19. Uchiyama.T., Sugiyama, T., Quan, Y.S., et al (1999): Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside. Pharm. Pharmacol. 51, 1241–1250.

    CAS  Google Scholar 

  20. Sakai, M., Imai, T., Ohtake, H., et al (1999): Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers. J. Pharm. Pharmacol. 51, 27–33.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Drug Metabolism and Pharmacokinetic Research Center, China Pharmaceutical University, 210038, Nanjing, People’s Republic of China

    C. R. Huang, G. J. Wang, X. L. Wu, H. Li, H. T. Xie, H. Lv & J. G. Sun

Authors
  1. C. R. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. J. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X. L. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. T. Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. G. Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, C.R., Wang, G.J., Wu, X.L. et al. Absorption enhancement study of astragaloside IV based on its transport mechanism in Caco-2 cells. European Journal of Drug Metabolism and Pharmacokinetics 31, 5–10 (2006). https://doi.org/10.1007/BF03190635

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190635

Keywords

Search

Navigation